We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+17.55%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$141B
AUM Growth
+$28.7B
Cap. Flow
+$7.51B
Cap. Flow %
5.32%
Top 10 Hldgs %
12.18%
Holding
4,838
New
647
Increased
1,556
Reduced
1,611
Closed
532

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.2B
2
NVDA icon
NVIDIA
NVDA
+$1.02B
3
TMUS icon
T-Mobile US
TMUS
+$911M
4
NFLX icon
Netflix
NFLX
+$699M
5
MU icon
Micron Technology
MU
+$672M

Top Sells

Rank Stock Value
1
GEV icon
GE Vernova
GEV
+$768M
2
HOOD icon
Robinhood
HOOD
+$643M
3
SCHW
Charles Schwab
SCHW
+$534M
4
MSFT icon
Microsoft
MSFT
+$493M
5
INTU icon
Intuit
INTU
+$472M

Sector Composition

Rank Sector Weight
1 Technology 16.33%
2 Healthcare 8.66%
3 Consumer Discretionary 8.33%
4 Financials 6.44%
5 Industrials 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHPGR
4126
ChampionsGate Acquisition Corp Rights
CHPGR
$12.5K ﹤0.01%
+125,000
New +$19.3K
LOTWW
4127
Lotus Technology Inc Warrants
LOTWW
$12.4K ﹤0.01%
117,840
EONR.WS
4128
EON Resources Warrants
EONR.WS
$12.3K ﹤0.01%
240,900
ONMDW icon
4129
OneMedNet Corp Warrant
ONMDW
$912K
$12.2K ﹤0.01%
420,000
EMCGR
4130
DELISTED
Embrace Change Acquisition Corp Rights
EMCGR
$11.4K ﹤0.01%
100,000
GDEVW icon
4131
GDEV Inc Warrant
GDEVW
$40.5K
$11.4K ﹤0.01%
575,000
IPCXR
4132
DELISTED
Inflection Point Acquisition Corp III Rights
IPCXR
$9.95K ﹤0.01%
+25,000
New +$8.88K
EURKR
4133
Eureka Acquisition Corp Right
EURKR
$9.9K ﹤0.01%
45,000
OSRHW
4134
OSR Health Warrant
OSRHW
$256K
$9.68K ﹤0.01%
150,000
OIOWW
4135
OIO Group Warrants
OIOWW
$9.61K ﹤0.01%
310,000
RDZNW icon
4136
Roadzen Inc Warrants
RDZNW
$8.94K ﹤0.01%
175,000
ASBPW
4137
Aspire Biopharma Warrant
ASBPW
$314K
$8.94K ﹤0.01%
199,999
DISTW
4138
DELISTED
Distoken Acquisition Corporation Warrant
DISTW
$8.32K ﹤0.01%
75,000
ZEOWW
4139
Zeo Energy Corp Warrants
ZEOWW
$103K
$7.99K ﹤0.01%
125,000
SPKLW
4140
Spark I Acquisition Corp Warrant
SPKLW
$6.15M
$7.77K ﹤0.01%
40,596
ABPWW
4141
DELISTED
Abpro Holdings Warrant
ABPWW
$7.76K ﹤0.01%
375,000
CHEB.WS
4142
DELISTED
Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CHEB.WS
$7.69K ﹤0.01%
87,500
FERAR
4143
Fifth Era Acquisition Corp I Rights
FERAR
$7.63K ﹤0.01%
+27,143
New +$6.04K
FBYDW icon
4144
Falcon's Beyond Global Warrants
FBYDW
$12.2M
$7.21K ﹤0.01%
10,162
UCFIW
4145
CN Healthy Food Tech Group Warrant
UCFIW
$7.14K ﹤0.01%
119,035
ABVEW
4146
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$7.03K ﹤0.01%
137,500
FACWW
4147
Factorial Energy Inc Warrant
FACWW
$7.32M
$6.76K ﹤0.01%
+25,000
New +$7.3K
IBACR
4148
IB Acquisition Corp Right
IBACR
$6.18K ﹤0.01%
150,000
COCHW icon
4149
Envoy Medical Warrant
COCHW
$415K
$5.5K ﹤0.01%
113,431
ALCYW
4150
DELISTED
Alchemy Investments Acquisition Corp 1 Warrants
ALCYW
$5.29K ﹤0.01%
50,000

Similar funds

David Shaw's Q2 2025 Portfolio in Review

As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.

  • David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
  • David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
  • David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
  • David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
  • David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
  • David Shaw opened 647 new positions and closed 532 in Q2 2025.
  • David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.

Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.